# Prevalence of Multidrug Resistant Micro-organism Carriage in Patients Undergoing an ERCP in Four Different Countries

> **NCT05303662** · — · COMPLETED · sponsor: **Marco J. Bruno** · enrollment: 1244 (actual)

## Conditions studied

- Drug Resistance, Multiple, Bacterial
- Cholangiopancreatography, Endoscopic Retrograde

## Interventions

- **DIAGNOSTIC_TEST:** Multidrug-Resistant Organisms (MDRO) testing through rectal and oral/nasal swabs
- **DIAGNOSTIC_TEST:** MDRO-testing duodenal aspirate
- **DIAGNOSTIC_TEST:** Microbiome through rectal swab
- **DIAGNOSTIC_TEST:** Microbiome testing duodenal aspirate

## Key facts

- **NCT ID:** NCT05303662
- **Lead sponsor:** Marco J. Bruno
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-31
- **Primary completion:** 2024-12-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 1244 (ACTUAL)
- **Last updated:** 2025-08-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05303662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05303662, "Prevalence of Multidrug Resistant Micro-organism Carriage in Patients Undergoing an ERCP in Four Different Countries". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05303662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
